Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion

I. Stern, J. C. Wataha, J. B. Lewis, R. L.W. Messer, P. E. Lockwood, W. Y. Tseng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The objective of this study was to quantify the ability of sublethal concentrations of several gold compounds to differentially modulate the monocytic secretion of key cytokines that are important in the etiology of rheumatic diseases. Human THP1 monocytic cells were exposed to the anti-rheumatic drugs auranofin (AF), gold sodium thiomalate (GSTM) or HAuCl 4 (Au(III)) for 24-72 h. Succinate dehydrogenase (SDH) activity of the monocytes was used to determine sublethal concentrations. Monocytes were then exposed to sublethal concentrations of gold compounds for 72 h, and the activator lipopolysaccharide (LPS) was added (or not) to cultures for the last 6 h. The secretion of IL6, IL8, IL10, and TNFα were measured in cell supernatants using ELISA. Cytokine secretion was compared among concentrations and gold compounds. SDH experiments established a sublethal concentration range of 0-75 μM for GSTM and Au(III) and 0-0.5 μM for AF. In cytokine experiments, none of the compounds alone activated secretion of any of the cytokines, but all differentially (50-440%, p < 0.05) increased LPS-induced secretion of IL6 and IL8 over TNFα and IL10. In conclusion, sublethal concentrations of AF, GSTM, and Au(III) all may differentially modulate activation of monocytic cells, and this differential modulation may be important in the mechanisms of action of these compounds.

Original languageEnglish (US)
Pages (from-to)365-371
Number of pages7
JournalToxicology in Vitro
Volume19
Issue number3
DOIs
StatePublished - Apr 2005

Fingerprint

Gold Compounds
Auranofin
Gold Sodium Thiomalate
Modulators
Lipopolysaccharides
Cytokines
Succinate Dehydrogenase
Interleukin-8
Interleukin-10
Monocytes
Interleukin-6
Antirheumatic Agents
Rheumatic Diseases
Experiments
Chemical activation
Enzyme-Linked Immunosorbent Assay
Modulation

Keywords

  • Arthritis
  • Cytokines
  • Metal compounds
  • Toxicity

ASJC Scopus subject areas

  • Toxicology

Cite this

Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion. / Stern, I.; Wataha, J. C.; Lewis, J. B.; Messer, R. L.W.; Lockwood, P. E.; Tseng, W. Y.

In: Toxicology in Vitro, Vol. 19, No. 3, 04.2005, p. 365-371.

Research output: Contribution to journalArticle

Stern, I. ; Wataha, J. C. ; Lewis, J. B. ; Messer, R. L.W. ; Lockwood, P. E. ; Tseng, W. Y. / Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion. In: Toxicology in Vitro. 2005 ; Vol. 19, No. 3. pp. 365-371.
@article{64a2115e2bde4f2d996ff23ae8aebaf6,
title = "Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion",
abstract = "The objective of this study was to quantify the ability of sublethal concentrations of several gold compounds to differentially modulate the monocytic secretion of key cytokines that are important in the etiology of rheumatic diseases. Human THP1 monocytic cells were exposed to the anti-rheumatic drugs auranofin (AF), gold sodium thiomalate (GSTM) or HAuCl 4 (Au(III)) for 24-72 h. Succinate dehydrogenase (SDH) activity of the monocytes was used to determine sublethal concentrations. Monocytes were then exposed to sublethal concentrations of gold compounds for 72 h, and the activator lipopolysaccharide (LPS) was added (or not) to cultures for the last 6 h. The secretion of IL6, IL8, IL10, and TNFα were measured in cell supernatants using ELISA. Cytokine secretion was compared among concentrations and gold compounds. SDH experiments established a sublethal concentration range of 0-75 μM for GSTM and Au(III) and 0-0.5 μM for AF. In cytokine experiments, none of the compounds alone activated secretion of any of the cytokines, but all differentially (50-440{\%}, p < 0.05) increased LPS-induced secretion of IL6 and IL8 over TNFα and IL10. In conclusion, sublethal concentrations of AF, GSTM, and Au(III) all may differentially modulate activation of monocytic cells, and this differential modulation may be important in the mechanisms of action of these compounds.",
keywords = "Arthritis, Cytokines, Metal compounds, Toxicity",
author = "I. Stern and Wataha, {J. C.} and Lewis, {J. B.} and Messer, {R. L.W.} and Lockwood, {P. E.} and Tseng, {W. Y.}",
year = "2005",
month = "4",
doi = "10.1016/j.tiv.2004.11.001",
language = "English (US)",
volume = "19",
pages = "365--371",
journal = "Toxicology in Vitro",
issn = "0887-2333",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion

AU - Stern, I.

AU - Wataha, J. C.

AU - Lewis, J. B.

AU - Messer, R. L.W.

AU - Lockwood, P. E.

AU - Tseng, W. Y.

PY - 2005/4

Y1 - 2005/4

N2 - The objective of this study was to quantify the ability of sublethal concentrations of several gold compounds to differentially modulate the monocytic secretion of key cytokines that are important in the etiology of rheumatic diseases. Human THP1 monocytic cells were exposed to the anti-rheumatic drugs auranofin (AF), gold sodium thiomalate (GSTM) or HAuCl 4 (Au(III)) for 24-72 h. Succinate dehydrogenase (SDH) activity of the monocytes was used to determine sublethal concentrations. Monocytes were then exposed to sublethal concentrations of gold compounds for 72 h, and the activator lipopolysaccharide (LPS) was added (or not) to cultures for the last 6 h. The secretion of IL6, IL8, IL10, and TNFα were measured in cell supernatants using ELISA. Cytokine secretion was compared among concentrations and gold compounds. SDH experiments established a sublethal concentration range of 0-75 μM for GSTM and Au(III) and 0-0.5 μM for AF. In cytokine experiments, none of the compounds alone activated secretion of any of the cytokines, but all differentially (50-440%, p < 0.05) increased LPS-induced secretion of IL6 and IL8 over TNFα and IL10. In conclusion, sublethal concentrations of AF, GSTM, and Au(III) all may differentially modulate activation of monocytic cells, and this differential modulation may be important in the mechanisms of action of these compounds.

AB - The objective of this study was to quantify the ability of sublethal concentrations of several gold compounds to differentially modulate the monocytic secretion of key cytokines that are important in the etiology of rheumatic diseases. Human THP1 monocytic cells were exposed to the anti-rheumatic drugs auranofin (AF), gold sodium thiomalate (GSTM) or HAuCl 4 (Au(III)) for 24-72 h. Succinate dehydrogenase (SDH) activity of the monocytes was used to determine sublethal concentrations. Monocytes were then exposed to sublethal concentrations of gold compounds for 72 h, and the activator lipopolysaccharide (LPS) was added (or not) to cultures for the last 6 h. The secretion of IL6, IL8, IL10, and TNFα were measured in cell supernatants using ELISA. Cytokine secretion was compared among concentrations and gold compounds. SDH experiments established a sublethal concentration range of 0-75 μM for GSTM and Au(III) and 0-0.5 μM for AF. In cytokine experiments, none of the compounds alone activated secretion of any of the cytokines, but all differentially (50-440%, p < 0.05) increased LPS-induced secretion of IL6 and IL8 over TNFα and IL10. In conclusion, sublethal concentrations of AF, GSTM, and Au(III) all may differentially modulate activation of monocytic cells, and this differential modulation may be important in the mechanisms of action of these compounds.

KW - Arthritis

KW - Cytokines

KW - Metal compounds

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=13844281785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844281785&partnerID=8YFLogxK

U2 - 10.1016/j.tiv.2004.11.001

DO - 10.1016/j.tiv.2004.11.001

M3 - Article

C2 - 15713543

AN - SCOPUS:13844281785

VL - 19

SP - 365

EP - 371

JO - Toxicology in Vitro

JF - Toxicology in Vitro

SN - 0887-2333

IS - 3

ER -